Cargando…

sFlt-1/PlGF Ratio as a Predictive Marker in Women with Suspected Preeclampsia: An Economic Evaluation from a Swiss Perspective

In Switzerland, 2.3% of pregnant women develop preeclampsia. Quantification of the soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF) ratio has shown a diagnostic value in the second and third trimesters of pregnancy, in particular in ruling out preeclampsia within one we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hodel, Markus, Blank, Patricia R., Marty, Petra, Lapaire, Olav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710794/ https://www.ncbi.nlm.nih.gov/pubmed/31485276 http://dx.doi.org/10.1155/2019/4096847

Ejemplares similares

Efficiency of sFlt-1/PlGF Ratio in Preeclampsia Diagnosis
por: Tataru-Copos, Anca-Florina, et al.
Publicado: (2022)

Correlation of sFlt/PlGF ratio with severity of preeclampsia in an Indian population
por: Kumar, Namrata, et al.
Publicado: (2023)

Influence of the sFlt-1/PlGF Ratio on Clinical Decision-Making in Women with Suspected Preeclampsia
por: Klein, Evelyn, et al.
Publicado: (2016)

Predictive value of the sFlt-1/PlGF ratio in women with suspected preeclampsia: An update (Review)
por: Velegrakis, Alexandros, et al.
Publicado: (2023)

sFLT1, PlGF, the sFLT1/PlGF Ratio and Their Association with Pre-Eclampsia in Twin Pregnancies—A Review of the Literature
por: Sapantzoglou, Ioakeim, et al.
Publicado: (2023)

Diagnostic accuracy of sFlt1/PlGF ratio as a marker for preeclampsia
por: Nikuei, Pooneh, et al.
Publicado: (2020)

A comparison of the diagnostic utility of the sFlt-1/PlGF ratio versus PlGF alone for the detection of preeclampsia/HELLP syndrome
por: Stepan, H., et al.
Publicado: (2016)

Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany
por: Schlembach, Dietmar, et al.
Publicado: (2018)

Increased sFlt-1 to PlGF Ratio in Women Who Subsequently Develop Preeclampsia
por: Kim, Shin-Young, et al.
Publicado: (2007)

Difference of concentration of placental soluble fms-like tyrosine kinase-1(sFlt-1), placental growth factor (PlGF), and sFlt-1/PlGF ratio in severe preeclampsia and normal pregnancy
por: Gurnadi, Jeffry Iman, et al.
Publicado: (2015)

Reduced expression in preterm birth of sFLT-1 and PlGF with a high sFLT-1/PlGF ratio in extracellular vesicles suggests a potential biomarker
por: Hussein, Sama, et al.
Publicado: (2022)

sFlt‐1/PlGF ratio test for pre‐eclampsia: an economic assessment for the UK
por: Vatish, M., et al.
Publicado: (2016)

The sFlt-1/PlGF Ratio Trend Is Useful in Predicting Preeclampsia Severity in Hyperreactio Luteinalis Complicated with Preeclampsia
por: Miyatake, Risa, et al.
Publicado: (2023)

The sFlt-1/PlGF Ratio in Pregnant Patients Affected by COVID-19
por: Kosinska-Kaczynska, Katarzyna, et al.
Publicado: (2023)

A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia
por: Pant, Vivek, et al.
Publicado: (2019)

Relationship between the sFlt-1/PlGF ratio and the optical coherence tomographic features of chorioretina in patients with preeclampsia
por: Lee, Jaekyoung, et al.
Publicado: (2021)

Decision Threshold for Kryptor sFlt‐1/PlGF Ratio in Women With Suspected Preeclampsia: Retrospective Study in a Routine Clinical Setting
por: Andersen, Lise Lotte Torvin, et al.
Publicado: (2021)

Placental and maternal sFlt1/PlGF expression in gestational diabetes mellitus
por: Nuzzo, Anna Maria, et al.
Publicado: (2021)

Evaluation of Angiogenic Factors (PlGF and sFlt-1) in Pre-eclampsia Diagnosis
por: Sá, Catherine Primo Nogueira de, et al.
Publicado: (2020)

Implementation of the sFlt-1/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice
por: Stepan, H, et al.
Publicado: (2015)

Economic evaluation of the sFlt-1/PlGF ratio for the short-term prediction of preeclampsia in a Japanese cohort of the PROGNOSIS Asia study
por: Ohkuchi, Akihide, et al.
Publicado: (2021)

Role of biomarkers (sFlt-1/PlGF) in cases of COVID-19 for distinguishing preeclampsia and guiding clinical management
por: Nobrega, Guilherme M., et al.
Publicado: (2023)

Predictive Model for Preeclampsia Combining sFlt-1, PlGF, NT-proBNP, and Uric Acid as Biomarkers
por: Garrido-Giménez, Carmen, et al.
Publicado: (2023)

sFlt-1/PlGF ratio in hypertensive disorders of pregnancy in patients affected by COVID-19
por: Soldavini, Chiara Maria, et al.
Publicado: (2022)

The Impact of Increased Maternal sFlt-1/PlGF Ratio on Motor Outcome of Preterm Infants
por: Middendorf, Lisa, et al.
Publicado: (2022)

sFlt-1, Not PlGF, Is Related to Twin Gestation Choronicity in the First and Third Trimesters of Pregnancy
por: Kozłowski, Szymon, et al.
Publicado: (2021)

sFlt-1/PlGF ratio for prediction of preeclampsia in clinical routine: A pragmatic real-world analysis of healthcare resource utilisation
por: Dathan-Stumpf, Anne, et al.
Publicado: (2022)

Accurate Prediction of Total PlGF (Placental Growth Factor) From Free PlGF and sFlt-1 (Soluble Fms-Like Tyrosine Kinase-1): Evidence for Markedly Elevated PlGF Levels in Women With Acute Fatty Liver of Pregnancy
por: Neuman, Rugina I., et al.
Publicado: (2021)

sFlt-1/PlGF Ratio in Prediction of Short-Term Neonatal Outcome of Small for Gestational Age Neonates
por: Witwicki, Jacek, et al.
Publicado: (2021)

The sFlt-1/PlGF Ratio in Patients Affected by Gestational Diabetes and SARS-CoV-2 Infection
por: Di Martino, Daniela Denis, et al.
Publicado: (2022)

Maternal Serum Angiogenic Factor sFlt-1 to PlGF Ratio in Preeclampsia: A Useful Marker for Differential Diagnosis and Prognosis Evaluation in Chinese Women
por: Lou, Wei-zhen, et al.
Publicado: (2019)

Short-term prediction of preeclampsia using the sFlt-1/PlGF ratio: a subanalysis of pregnant Japanese women from the PROGNOSIS Asia study
por: Ohkuchi, Akihide, et al.
Publicado: (2021)

Prediction of Adverse Pregnancy Outcome Related to Placental Dysfunction Using the sFlt-1/PlGF Ratio: A Narrative Review
por: Graupner, Oliver, et al.
Publicado: (2021)

Comment on: The sFlt-1 to PlGF ratio in pregnant women with rheumatoid arthritis: impact of disease activity and sulfasalazine use. Reply
por: Smeele, Hieronymus T W, et al.
Publicado: (2021)

Literature Review: The sFlt1/PlGF Ratio and Pregestational Maternal Comorbidities: New Risk Factors to Predict Pre-Eclampsia
por: Karpova, Nataliia Sergeevna, et al.
Publicado: (2023)

Soluble fms-Like Tyrosine Kinase 1 (sFlt1), Endoglin and Placental Growth Factor (PlGF) in Preeclampsia among High Risk Pregnancies
por: Powers, Robert W., et al.
Publicado: (2010)

sFlt‐1/PlGF for prediction of early‐onset pre‐eclampsia: STEPS (Study of Early Pre‐eclampsia in Spain)
por: Perales, A., et al.
Publicado: (2017)

Slowing of fetal growth and elevated maternal serum sFLT1:PlGF are associated with early term spontaneous labor
por: Sovio, Ulla, et al.
Publicado: (2021)

Changes in concentrations of melatonin, PlGF, and cytokines in women with preeclampsia
por: Savka, Ruslan Florovych, et al.
Publicado: (2023)

Short-Term Prediction of Adverse Outcomes Using the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) Ratio in Asian Women With Suspected Preeclampsia
por: Bian, Xuming, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8rgr0drg1hpvn64timmdrkh6p4